MBB Public Markets’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,101
Closed -$284K 401
2025
Q2
$284K Sell
1,101
-249
-18% -$59.4K 0.03% 160
2025
Q1
$302K Buy
+1,350
New +$315K 0.03% 426
2024
Q4
Sell
-1,350
Closed -$330K 464
2024
Q3
$330K Sell
1,350
-9,185
-87% -$2.05M 0.02% 309
2024
Q2
$2.02M Buy
+10,535
New +$2.14M 0.04% 353
2022
Q1
Sell
-1,217
Closed -$317K 372
2021
Q4
$317K Buy
+1,217
New +$316K 0.01% 340

Other funds holding RMD

MBB Public Markets's RMD Position: Q3 2025 in Review

MBB Public Markets sold out of ResMed (RMD) in Q3 2025, closing a stake of 1,101 shares — an estimated $284K sold.

MBB Public Markets first reported a position in RMD in Q4 2021 and held it in 5 quarters. The position peaked at $2.02M in Q2 2024. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • MBB Public Markets reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • MBB Public Markets sold 1,101 ResMed shares in Q3 2025, an estimated $284K.
  • MBB Public Markets first reported a position in ResMed in Q4 2021 and held it in 5 quarters.
  • MBB Public Markets's ResMed position peaked at $2.02M in Q2 2024.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on MBB Public Markets's 13F filing for Q3 2025, filed 14 Nov 2025.